Pfenex Public
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
%20.jpg)
%20.jpg)
Technology:
Cancer
Headquarters:
San Diego, California, United States
Funding Status:
M&A
Investment Stage:
N/A
Founded Date:
2009
Number Of Exists:
N/A
Estimated Revenue:
$10M to $50M
Employee Number:
11-50
Industry:
PharmTech
Investor Type:
N/A